Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 120.938 | 78 |
GSM780708 | Untreated after 4 days (C2_1) | 104.195 | 76 |
GSM780709 | Untreated after 4 days (C3_1) | 109.031 | 76 |
GSM780719 | Untreated after 4 days (C1_2) | 150.567 | 80 |
GSM780720 | Untreated after 4 days (C2_2) | 107.011 | 76 |
GSM780721 | Untreated after 4 days (C3_2) | 116.176 | 77 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 108.183 | 76 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 123.937 | 78 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 113.649 | 77 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 92.0701 | 74 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 119.25 | 78 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 103.496 | 76 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 144.276 | 80 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 115.923 | 77 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 114.994 | 77 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 144.389 | 80 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 122.342 | 78 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 139.734 | 80 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 121.929 | 78 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 135.558 | 79 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 111.432 | 77 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 130.369 | 79 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 117.893 | 77 |